Repaglinide-Cyclodextrin complexes: Preparation, Characterization and in vivo evaluation of antihyperglycemic activity

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 70, Issue 1-2, 2011, Pages 217-225

  Desai, Neha S ^a   Bramhane, Dinesh M ^a   Nagarsenker, Mangal S ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Cyclodextrin; Hydroxypropyl cyclodextrin; In vitro dissolution; In vivo study; Repaglinide

Indexed keywords

EID: 79956030072     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-010-9895-0     Document Type: Article

References (20)

1. C Culy B Jarvis 2001 Repaglinide, a review of its therapeutic use in type 2 diabetes mellitus Drugs 61 1625 1660 10.2165/00003495-200161110-00008 1:CAS:528:DC%2BD3MXnvVCqs70%3D (Pubitemid 32905281)
2. W Malaisse 1999 Repaglinide, a new oral antidiabetic agent: a review of recent preclinical studies Eur. J. Clin. Invest. 29 21 29 10.1046/j.1365-2362. 1999.00001.x 1:CAS:528:DyaK1MXktFOhsLc%3D (Pubitemid 29267938)
3. JF Blicklé 2006 Meglitinide analogues: a review of clinical data focused on recent trials Diabetes Metab. 32 113 120 10.1016/S1262-3636(07)70257- 4
4. TC Marbury JL Ruckle V Hatorp MP Andersen KK Nielsen WC Huang P Strange 2000 Pharmacokinetics of repaglinide in subjects with renal impairment Clin. Pharmacol. Ther. 67 7 15 10.1067/mcp.2000.103973 1:CAS:528:DC%2BD3cXhtV2rsbY%3D (Pubitemid 30078382)
5. T Marbury W Huang P Strange H Lebovitz 1999 Repaglinide versus glyburide: a one-year comparison trial Diabetes Res. Clin. Pract. 43 155 166 10.1016/S0168-8227(99)00002-9 1:CAS:528:DyaK1MXhvFGhtLw%3D (Pubitemid 29202125)
6. P Sinswat ME Matteucci KP Johnston RO Williams III 2007 Dissolution rates and supersaturation behavior of amorphous repaglinide particles produced by controlled precipitation J. Biomed. Nanotechnol. 3 18 27 10.1166/jbn.2007.001 1:CAS:528:DC%2BD2sXkvVemsbo%3D (Pubitemid 351877124)
7. T Purvis ME Mattucci MT Crisp KP Johnston RO Williams III 2007 Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process AAPS PharmSciTech. 8 3 E1 E9 10.1208/pt0803058
8. C Nicolescu C Aramǎ CM Monciu 2010 Preparation and characterization of inclusion complexes between repaglinide and β-cyclodextrin, 2-hydroxypropyl β-cyclodextrin and randomly methylated β-cyclodextrin Farmacia 58 78 88 1:CAS:528:DC%2BC3cXjsFyisLw%3D
9. T Loftsson M Brewster 1996 Pharmaceutical application of cyclodextrins. I. Drug solubilization and stabilization J. Pharm. Sci. 85 1017 1025 10.1021/js950534b 1:CAS:528:DyaK28XlsFSrsr4%3D (Pubitemid 26338912)
10. RA Rajewski VJ Stella 1996 Pharmaceutical application of cyclodextrins. II. In vivo drug delivery J. Pharm. Sci. 85 1142 1169 10.1021/js960075u 1:CAS:528:DyaK28XmtFKgu70%3D (Pubitemid 26372882)
11. EMM Del Valle 2004 Cyclodextrins and their uses: a review Process. Biochem. 39 1033 1046 10.1016/S0032-9592(03)00258-9 (Pubitemid 38527174)
12. T Higuchi KA Connors 1965 Phase-solubility techniques Adv. Anal. Chem. Instrum. 4 117 212 1:CAS:528:DyaF2MXktlGitrg%3D
13. United States Pharmacopeia 24/NF19. The Official Compendia of Standards, Asian ed. United States Pharmacopoeial Convention Inc., Rockville, MD (2000)
14. KA Khan 1975 The concept of dissolution efficiency J. Pharm. Pharmacol. 27 48 49 10.1111/j.2042-7158.1975.tb09378.x 1:CAS:528:DyaE2MXhsVCru7o%3D
15. ML Manca M Zaru G Ennas D Valenti C Cinico G Loy AM Fadda 2008 Diclofenac-β-cyclodextrin binary systems: physicochemical characterization and in vitro dissolution and diffusion studies AAPS PharmSciTech. 6 3 E44 E472
16. B Gordon LJ Schep MY Tan 1999 Improvement of the in vitro dissolution of praziquantel by complexation with α-, β- and γ-cyclodextrins Int. J. Pharm. 179 65 71 10.1016/S0378-5173(98)00382-2 (Pubitemid 29115061)
17. Q Bekers EV Uijtendaal JH Beijnen A Bult WJ Underberg 1991 Cyclodextrins in the pharmaceutical field Drug Dev. Ind. Pharm. 17 1503 1549 10.3109/03639049109026630 1:CAS:528:DyaK3MXltF2rurc%3D
18. F Djedaine SZ Lin B Perly D Wouessidjewe 1990 High-field nuclear magnetic resonance techniques for the investigation of a β-cyclodextrin: indomethacin inclusion complex J. Pharm. Sci. 79 643 646 10.1002/jps.2600790721 (Pubitemid 20222735)
19. VK Smith TT Ndou AM De La Peña IM Warner 1991 Spectral characterization of β-cyclodextrin: Triton X-100 complexes J. Incl. Phenom. Mol. Recognit. Chem. 10 471 484 10.1007/BF01061077 1:CAS:528:DyaK3MXltlylt7s%3D
20. LP Jordheim G Degobert R Diab S Peyrottes C Perigaud C Dumontet H Fessi 2009 Inclusion complexes of a nucleotide analogue with hydroxypropyl-beta- cyclodextrin J. Incl. Phenom. Macrocycl. Chem. 63 11 16 10.1007/s10847-008-9483- 8 1:CAS:528:DC%2BD1MXpvVeqsA%3D%3D